Use of the aromatase inhibitor letrozole to treat male infertility.
Report the case of induction of spermatogenesis with the aromatase inhibitor letrozole. Case report. University Infertility center. A 31-year-old man with primary infertility, normal volume azoospermia, normal follicle stimulating hormone (FSH) levels and pattern of nonobstructive azoospermia (NOA) on a testicular biopsy. The patient was given the aromatase inhibitor letrozole for 4 months and had repeated FSH, testosterone, LH levels, semen analyses, and finally a testicular biopsy. Results of a testis biopsy. Testis biopsy showed normal spermatogenesis following 4 months of letrozole therapy. This is the first case report on the use of letrozole to treat male infertility and the first case report on the induction of spermatogenesis in a man with NOA using any aromatase inhibitor.